Product information

Litican 50 mg/2 ml
6 x 2 ml
alizapride
0818724
9.8 / 10
Locked

Product properties

59338-93-1
A03FA05
Sanofi Belgium
Solution for injection
€2.32
BE122823
03582910086925
M1
Public
122823-01

Pharmacist Assessment

Normally available

This product has good current availability (score 9.8/10) and is historically stable (score 🔒/10). No action required.

Note: commercialization of this product will be stopped on 31/12/2027.

Equivalent products

Tier A: Direct equivalents

Tier B: Galenic alternatives

Tier C: Strength alternatives

Tier D: ATC equivalents (parallel import)

Tier E: Active substances (magistral)

Stock overview

Availability in Freemium
  • 18 of 18 warehouse locations have stock
  • 3 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Status history (PharmaStatus)

Commercialization stopped Planned
From 31/12/2027

Commercial reasons

Adaptation of the treatment is possible
Available Active
Until 30/12/2027

Composition

2 ingredients

Substance Type Strength CAS
Active ingredient
55.8 mg
59338-87-3
Excipient
13 mg

Additional information

Availability statistics

Available
0 days
2
0